Bristol Myers Squibb Co (BMY)
Bristol Myers Squibb Co (BMY) is a Healthcare stock tracked by StreetAlpha. It last closed at $58.81 on Oct 5, down 3.83% on the day. BMY reports earnings on Thu, Oct 29, 2026. The average 12-month price target from 12 analysts is $68.58 (+16.6% from the last close), with a high of $82.00 and a low of $59.00. Analyst consensus is Buy, based on the latest ratings from 12 firms (6 buy, 6 hold, 0 sell). Over the past 90 days StreetAlpha recorded 7 whale options trades in BMY, 57% of them bullish and 43% bearish. In the past 30 days there were 9 dark pool prints totaling $9.2M, the largest $2.2M.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →Based on 12 analysts who set a price target on BMY in the past 90 days. The average target is $68.58, with a high of $82.00 and a low of $59.00, compared with the last close of $58.81.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 5 | Leerink Partners | Downgrade | Hold | $59 |
| Sep 16 | Piper Sandler | Reiterated | Buy | $82 |
| Sep 10 | HSBC | Maintained | Hold | $65 |
| Aug 5 | Argus Research | Upgrade | Buy | $75 |
| Aug 3 | Citigroup | Maintained | Hold | $70 |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BMY is in one of them and how their past BMY trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered BMY in an article yet. Here's the latest on the wider market.